Merck & Co.'s peptides could be undergoing a transformation into oral tablets thanks to a $493 million licensing deal the ...

In the US, healthcare costs and prices have been increasing. According to the Centers for Medicare & Medicaid Services, U.S.

We recently published a list of 10 Best Pharma Stocks to Buy for Long Term Growth. In this article, we are going to take a ...

Experts say the tariffs are unlikely to bring back production of generic medicines, given their slim profit margins ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Merck (NYSE: MRK) is a top healthcare company with one of the best drugs ever made in its portfolio ... Merck does have other products that can also generate billions in revenue in the future.

Merck Life Science South Africa, a leading science and technology company, is excited to announce its participation as a bronze sponsor at Analytica Lab Africa 2025. This major trade fair for ...

Merck & Co., Inc. is a health care company ... animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.

The drugmaker also has other products that may generate billions of revenue in the future. During the last three months of 2024, Merck achieved solid 9% revenue growth (excluding the impact of ...